Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Canavan disease is a devastating disease of infants which affects their neural development and leads to mental retardation and early death. It occurs in 1 in 6,400 persons in the…

Continue ReadingDeveloping a therapeutic candidate for Canavan disease using induced pluripotent stem cell

Development of RNA-based approaches to stem cell gene therapy for HIV

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Despite significant advances in treatment and prevention programs, HIV infection with progression to Acquired Immunodeficiency Syndrome (AIDS) is still prevalent in California. The CDC Estimates >56,000 new cases of HIV…

Continue ReadingDevelopment of RNA-based approaches to stem cell gene therapy for HIV

Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Diabetic foot ulcers (DFU), chronic, non-healing wounds on the feet of diabetic patients, present a serious challenge to global health. These ulcers affect between 15-25% of the 18-21 million Americans…

Continue ReadingBone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds

Stem cell-based carriers for RCR vector delivery to glioblastoma

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Modified viruses can be used to infect tumor cells and alter the tumor cell to make anti-tumor proteins. Most researchers use virus that can infect and modify the tumor cell…

Continue ReadingStem cell-based carriers for RCR vector delivery to glioblastoma

Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder. It is characterized by motor impairment such as slowness of movements, shaking and gait disturbances. Age is the most consistent…

Continue ReadingCrosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model

Human retinal progenitor cells as candidate therapy for retinitis pigmentosa

  • Post author:
  • Post published:May 10, 2025
  • Post category:

The targeted disease is retinitis pigmentosa (RP), is a severe form of blindness that runs in families. This disease is not overly common, yet represents an attainable near term target…

Continue ReadingHuman retinal progenitor cells as candidate therapy for retinitis pigmentosa

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Banking transplant ready dopaminergic neurons using a scalable process

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Parkinson's disease (PD) is a devastating movement disorder caused by the death of dopaminergic neurons (a type of nerve cells in the central nervous system) present in the midbrain. These…

Continue ReadingBanking transplant ready dopaminergic neurons using a scalable process

New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

  • Post author:
  • Post published:May 10, 2025
  • Post category:

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death in the U.S. This devastating disease affects 1 child in every 6,000-10,000 live births, with a North American…

Continue ReadingNew Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells
  • Go to the previous page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 74
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us